Product Description
This book presents information about cancer incidence for populations in Cyprus, Egypt (Gharbiah Region), Israel (Jews and Arabs), and Jordan for the period 1996-2001. The MECC findings are compared with those from the US Surveillance, Epidemiology, and End Results (SEER) Program. For most of the cancers described in this monograph, incidence is expressed as age-standardized incidence rates (ASRs) per 100,000 population. The ASR is a summary measure that permits comparison of incidence rates across populations while adjusting for differences in age distributions. ASRs for childhood cancers are expressed per
1 million population.Product Description
This book presents information about cancer incidence for populations in Cyprus, Egypt (Gharbiah Region), Israel (Jews and Arabs), and Jordan for the period 1996-2001. The MECC findings are compared with those from the US Surveillance, Epidemiology, and End Results (SEER) Program. For most of the cancers described in this monograph, incidence is expressed as age-standardized incidence rates (ASRs) per 100,000 population. The ASR is a summary measure that permits comparison of incidence rates across populations while adjusting for differences in age distributions. ASRs for childhood cancers are expressed per
1 million population.

Cancer Incidence in Four Member Countries Compared with US SEER

Product Description
Au sein de la fédération médico-chirurgicale de pathologie digestive du CHU d’Amiens, il a été développé depuis 2001 une prise en charge multidisciplinaire et originale des occlusion colique sur stenose néoplasique. La mise en place d’une prothèse metallique auto-expansible sous contrôle radio-endoscopique permet de traiter en urgence l’occlusion. Ce mode de prise en charge permet de réaliser une chirurgie optimale car non soumise à l’urgence et d’améliorer l’état physiologique du patient dans l’intervalle entre prothèse en urgence et chirurgie éléctive. Nous avons souhaité par ce travail évaluer si ce mode de prise en charge est optimal carcinologiquement. Ce travail est le fruit des efforts conjoints entre radiologues, gastro-enterologues, anesthésistes et chirurgiens.

Cancer du colon en occlusion: Faisabilité et résultats carcinologiques de la séquence stent-chirurgie

Product Description
Red meat, alcohol and cigarettes spell disaster if you are at risk of colon cancer…but what else can put you in the danger zone? New studies have found genetic links to help detect and prevent this killer cancer. A must read for those who have a genetic predisposition to colon cancer, plus the latest on a cancer vacine.

Project Webster represents a new publishing paradigm, allowing disparate content sources to be curated into cohesive, relevant, and informative books. To date, this content has been curated from Wikipedia articles and images under Creative Commons licensing, although as Project Webster continues to increase in scope and dimension, more licensed and public domain content is being added. We believe books such as this represent a new and exciting lexicon in the sharing of human knowledge.

Alcohol, Diet and Cancer: The Facts Behind the Prevention and Early Detection of colon Cancer

Product Description
This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on colon and rectal cancer: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. Colon cancer is a disease in which malignant (cancer) cells form in the tissues of the colon. The colon is part of the body s digestive system. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The digestive system is made up of the esophagus, stomach, and the small and large intestines. The first 6 feet of the large intestine are called the large bowel or colon. The last 6 inches are the rectum and the anal canal. The anal canal ends at the anus (the opening of the large intestine to the outside of the body). For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor references and texts have detailed technical information and clinical background material. Documents from the National Cancer Institute, Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Medline, Centers for Medicare and Medicaid Services (CMS), and Occupational Health and Safety Administration (OSHA) are included. In addition to disease-specific information, there is extensive coverage of the broad subject of cancer and its prevention and treatment (surgery, chemotherapy, radiation, advanced treatments, managing side effects). There is no other reference that is as fast, convenient, and portable – everything you need to know, from the federal sources you trust. Since navigating the Internet to find medical information can be confusing, our exclusive “Guide to Leading Medical Websites 2009″ has updated links to the 67 best sites! Weblinks let you quickly check for the latest clinical updates directly from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Comprehensive cancer coverage includes: FDA Office of Oncology Drug Products, Oncology Tools – approved drugs, patient liaison * Dictionary of Cancer Terms (4000 items) * Division of Cancer Biology * Cancer Bulletin – archive of informative articles from NCI publication since 2004 * Cancers by Body Location, System * A-Z list of cancers * Clinical Trials * Complementary and Alternative Medicine * Coping – Complications and Side Effects – fatigue, pain, cardiopulmonary syndromes, cognitive disorders and delirium; fever, sweats, hot flashes; gastrointestinal complications, hypercalcemia; lymphedema; pruritus; sexuality and reproduction; sleep; nutrition; eating hints; emotions, anxiety, depression, adjustment, post-traumatic stress disorder; substance abuse; transitional care planning; radiation, home care, when cancer returns; Care for the Caregiver; Survivorship – end of life issues, advance directives, coping with advanced cancer, Hospice, Loss, Grief, and Bereavement * Division of Cancer Treatment and Diagnosis * Drug Development and Approval * Approved Oncology Drugs * Drug Dictionary – technical definitions and synonyms * Drug Information Summaries * Factsheets by cancer type, risk factors and possible causes, prevention, detection, diagnosis, therapy, support, coping, resources, tobacco and smoking cessation * Prevention, Genetics * Publications – specific cancers, treatment, trials, coping, testing, risks, nutrition * Screening and Testing * Support – organizations, finances and insurance * Chemotherapy, Radiation Therapy, Surgery, Cryosurgery, Laser, Hyperthermia, Targeted

21st Century Ultimate Medical Guide to Colon and Rectal Cancer – Authoritative, Practical Clinical Information for Physicians and Patients, Treatment Options

Product Description
Authoritative information and practical advice from the nation’s cancer experts about gastrointestinal carcinoid tumors includes official medical data on signs, symptoms, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of gastrointestinal carcinoid..

Comprehensive data on clinical trials related to gastrointestinal carcinoids is included – with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.
A gastrointestinal carcinoid tumor is cancer that forms in the lining of the gastrointestinal tract. The gastrointestinal tract includes the stomach, small intestine, and large intestine. These organs are part of the digestive system, which processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) in foods that are eaten and helps pass waste material out of the body. Gastrointestinal carcinoid tumors develop from a certain type of hormone -making cell in the lining of the gastrointestinal tract. These cells produce hormones that help regulate digestive juices and the muscles used in moving food through the stomach and intestines. A gastrointestinal carcinoid tumor may also produce hormones. Carcinoid tumors that start in the rectum (the last several inches of the large intestine) usually do not produce hormones. Gastrointestinal carcinoid tumors grow slowly. Most of them occur in the appendix (an organ attached to the large intestine), small intestine, and rectum. It is common for more than one tumor to develop in the small intestine. Having a carcinoid tumor increases a person’s chance of getting other cancers in the digestive system, either at the same time or later.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute’s Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward – Life After Cancer Treatment
Chemotherapy and You

This is a privately authored news service and educational publication of Progressive Management. For over a quarter of a century, our news, educational, technical, scientific, and medical publications have made unique and valuable references accessible to all people. Our e-books put knowledge at your fingertips, and an expert in your pocket!Product Description
Authoritative information and practical advice from the nation’s cancer experts about gastrointestinal carcinoid tumors includes official medical data on signs, symptoms, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of gastrointestinal carcinoid..

Comprehensive data on clinical trials related to gastrointestinal carcinoids is included – with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.
A gastrointestinal carcinoid tumor is cancer that forms in the lining of the gastrointestinal tract. The gastrointestinal tract includes the stomach, small intestine, and large intestine. These organs are part of the digestive system, which processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) in foods that are eaten and helps pass waste material out of the body. Gastrointestinal carcinoid tumors develop from a certain type of hormone -making cell in the lining of the gastrointestinal tract. These cells produce hormones that help regulate digestive juices and the muscles used in moving food through the stomach and intestines. A gastrointestinal carcinoid tumor may also produce hormones. Carcinoid tumors that start in the rectum (the last several inches of the large intestine) usually do not produce hormones. Gastrointestinal carcinoid tumors grow slowly. Most of them occur in the appendix (an organ attached to the large intestine), small intestine, and rectum. It is common for more than one tumor to develop in the small intestine. Having a carcinoid tumor increases a person’s chance of getting other cancers in the digestive system, either at the same time or later.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute’s Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward – Life After Cancer Treatment
Chemotherapy and You

This is a privately authored news service and educational publication of Progressive Management. For over a quarter of a century, our news, educational, technical, scientific, and medical publications have made unique and valuable references accessible to all people. Our e-books put knowledge at your fingertips, and an expert in your pocket!

21st Century Adult Cancer Sourcebook: Gastrointestinal Carcinoid Tumors – Appendix, Rectal, Small Bowel, Gastric, Colon, Pancreatic, Regional, Metastatic, Carcinoid Syndrome

Product Description
This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on colon and rectal cancer: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. Colon cancer is a disease in which malignant (cancer) cells form in the tissues of the colon. The colon is part of the body’s digestive system. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The digestive system is made up of the esophagus, stomach, and the small and large intestines. The first 6 feet of the large intestine are called the large bowel or colon. The last 6 inches are the rectum and the anal canal. The anal canal ends at the anus (the opening of the large intestine to the outside of the body). For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor references and texts have detailed technical information and clinical background material. Documents from the National Cancer Institute, Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Medline, Centers for Medicare and Medicaid Services (CMS), and Occupational Health and Safety Administration (OSHA) are included. In addition to disease-specific information, there is extensive coverage of the broad subject of cancer and its prevention and treatment (surgery, chemotherapy, radiation, advanced treatments, managing side effects). There is no other reference that is as fast, convenient, and portable – everything you need to know, from the federal sources you trust. Since navigating the Internet to find medical information can be confusing, our exclusive “Guide to Leading Medical Websites 2009″ has updated links to the 67 best sites! Weblinks let you quickly check for the latest clinical updates directly from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Comprehensive cancer coverage includes: FDA Office of Oncology Drug Products, Oncology Tools – approved drugs, patient liaison * Dictionary of Cancer Terms (4000 items) * Division of Cancer Biology * Cancer Bulletin – archive of informative articles from NCI publication since 2004 * Cancers by Body Location, System * A-Z list of cancers * Clinical Trials * Complementary and Alternative Medicine * Coping – Complications and Side Effects – fatigue, pain, cardiopulmonary syndromes, cognitive disorders and delirium; fever, sweats, hot flashes; gastrointestinal complications, hypercalcemia; lymphedema; pruritus; sexuality and reproduction; sleep; nutrition; eating hints; emotions, anxiety, depression, adjustment, post-traumatic stress disorder; substance abuse; transitional care planning; radiation, home care, when cancer returns; Care for the Caregiver; Survivorship – end of life issues, advance directives, coping with advanced cancer, Hospice, Loss, Grief, and Bereavement * Division of Cancer Treatment and Diagnosis * Drug Development and Approval * Approved Oncology Drugs * Drug Dictionary – technical definitions and synonyms * Drug Information Summaries * Factsheets by cancer type, risk factors and possible causes, prevention, detection, diagnosis, therapy, support, coping, resources, tobacco and smoking cessation * Prevention, Genetics * Publications – specific cancers, treatment, trials, coping, testing, risks, nutrition * Screening and Testing * Support – organizations, finances and insurance * Chemotherapy, Radiation Therapy, Surgery, Cryosurgery, Laser, Hyperthermia, Targeted * Understanding Cancer

2009 Conquering Cancer – The Empowered Patient’s Complete Reference to Colon and Rectal Cancer – Diagnosis, Treatment Options, Prognosis

Product Description
Summary This science-based book is the first to demonstrate that insufficient access to the sun’s ultraviolet-B (UV-B) irradiance, necessary for photosynthesis of vitamin D, increases the risk of progression in prostate cancer.

At least 80 per cent of our major circulating reservoir of the vitamin, 25-hydroxyvitamin D, is produced by casual exposure of unprotected skin to solar UV-B. The remainder is obtained from foods and supplements.

The author looks at five of the many populations characterized by elevated death rates from prostate cancer: African-North Americans, Norwegians, Swedes, Swiss, and Danes. He shows that insufficient photosynthesis is common to them all and describes the causative circumstances in each instance.

An in-depth review of the literature revealed that a substantial increase in the daily supply of vitamin D recommended for adult North Americans is urgently needed. Importantly, it showed that an increase of the magnitude envisaged would fall well within the range of values necessary for combining safety and efficacy.

The following examples illustrate the scope and tenor of the book:

· Evidence that calcitriol, a steroid hormone metabolized from 25-hydroxyvitamin D, inhibits proliferation of prostate cancer cells, as well as regulating the supply of calcium to bones and other organs.

· The capacity of calcitriol to induce cell cycle arrest (apoptosis) and decrease the harmfulness of insulin-like growth factors (IGF), known to be implicated in cancers of the prostate, the breast, and the colon.

· The significance of the term “gene-expression switch,” considered in the light of the ability of calcitriol and its receptor to modulate the transcription of numerous genes within the nuclei of cells.

· Provided that two prerequisites are met, the ability of the prostate to produce calcitriol within its cells.

· Details of an actual case of vitamin D toxicity after long-term mega-dosing with a

Sunlight, Vitamin D, and Prostate Cancer Risk: With References to Omega-3 Essential Fatty Acids, Breast Cancer and Colon Cancer

Product Description
Table of Contents

Introduction to Using Computer Aided Diagnosis for Medical Evaluation 3
Comparative Analysis of Computer Aided Detection 9

A Comparative Analysis of the Medical Image Analysis System 60 (MIAS) 20

FIRST RESULTS OF MEDICAL STUDY USING MIAS 60 LABORATORY  34

A Longitudinal, Retrospective Study Evaluating the Kanecki MIAS CAD in Mapping Cancer and the Progression 39

Status Report on Final Results of Study 07-010 for Computer Aided Detection 55

———————————————————

PART ONE – INTRODUCTION TO COMPUTER DIAGNOSIS

Introduction

This paper will discuss what is being done in using computers to aid in diagnosis and reading of MRI scans. The primary use of computers in diagnosis is that of a “second reader.” A second reader’s purpose is to validate or verify the first reader, an experiences physician or oncologist determination. We at Kanecki Associates, Inc have developed software that has had medical study evaluation at Wheaton, study 07-010, for validation of cranial cancer areas. The result of the study is that the program is 95% accuracy in diagnosing the significant areas with a 4% false negative rating.

What is computer aided detection (CAD)? Computer aided detection is a method of where the computer is used to read a MRI, PET, CT, or x-ray to make a medical diagnosis. Computer aided detection is referred to as CAD. The primary use of CAD is the cranial, abdominal, and colonoscopy areas.
With a MRI, magnetic resonance imaging, the computer is used to diagnose a patient with cancer in the cranial, abdominal, and colonoscopy areas. The cranial diagnosis uses a method known as the “3 Plane LOC” series. The term “LOC” refers to the different views of the brain as longitudinal, occipital, and cerebral. With the abdominal area, CAD is used to examine the onset of cancer from the external to the internal part of the body. CAD use is based on that of a second reader to validate the original diagnosis. A “second reader” is process whereby the original diagnosis is confirmed. CAD is used in areas of virtual colonoscopy. In the virtual colonoscopy use, the second reader provides another option to a traditional colonoscopy.
CAD is being used in mammography, but some studies do not support its’ use do to greater harm in using CAD for mammogram analysis of cancer. The issue is that CAD for mammogram use has a low success rate below 15%. In addition, CAD for mammography increases the need of biopsies for the patient, according to some studies.
The primary area where CAD is beginning to be used includes cranial, pulmonary, abdominal area, and colonoscopy. In the four areas mentioned, only virtual colonoscopy is where CAD is used as a pre-screen for cancer. In the cranial, pulmonary, and abdominal analysis, CAD is used as a second reader to the primary oncologist evaluation.
Computer aided detection is an emerging technology used in medicine for either as a second reader or a first reader in pre-screening of cancer. Colonoscopy is the leading field of CAD as a first reader, pre-screener.

Why computer is aided diagnosis research performed? Computer aided diagnosis, CAD, is performed to develop a technology to reduce reading errors. A reading error is where an expert may determine as area to be positive when it is not, requiring a biopsy, or when an expert determines an area to be negative, when it is positive, delaying the needed treatment of a patient. Some of the reading errors are caused form false-positives which require a biopsy for evaluation. A biopsy is a tissue specimen of the affected area. Another aspect is a false negative in which the patient loses critical time in treatment. A mis-reading can occur even without an expert reader due to various reasons. Therefore, CAD is researched as a way to help the physician and researcher to better serve the patient.Product Description
Table of Contents

Introduction to Using Computer Aided Diagnosis for Medical Evaluation 3
Comparative Analysis of Computer Aided Detection 9

A Comparative Analysis of the Medical Image Analysis System 60 (MIAS) 20

FIRST RESULTS OF MEDICAL STUDY USING MIAS 60 LABORATORY  34

A Longitudinal, Retrospective Study Evaluating the Kanecki MIAS CAD in Mapping Cancer and the Progression 39

Status Report on Final Results of Study 07-010 for Computer Aided Detection 55

———————————————————

PART ONE – INTRODUCTION TO COMPUTER DIAGNOSIS

Introduction

This paper will discuss what is being done in using computers to aid in diagnosis and reading of MRI scans. The primary use of computers in diagnosis is that of a “second reader.” A second reader’s purpose is to validate or verify the first reader, an experiences physician or oncologist determination. We at Kanecki Associates, Inc have developed software that has had medical study evaluation at Wheaton, study 07-010, for validation of cranial cancer areas. The result of the study is that the program is 95% accuracy in diagnosing the significant areas with a 4% false negative rating.

What is computer aided detection (CAD)? Computer aided detection is a method of where the computer is used to read a MRI, PET, CT, or x-ray to make a medical diagnosis. Computer aided detection is referred to as CAD. The primary use of CAD is the cranial, abdominal, and colonoscopy areas.
With a MRI, magnetic resonance imaging, the computer is used to diagnose a patient with cancer in the cranial, abdominal, and colonoscopy areas. The cranial diagnosis uses a method known as the “3 Plane LOC” series. The term “LOC” refers to the different views of the brain as longitudinal, occipital, and cerebral. With the abdominal area, CAD is used to examine the onset of cancer from the external to the internal part of the body. CAD use is based on that of a second reader to validate the original diagnosis. A “second reader” is process whereby the original diagnosis is confirmed. CAD is used in areas of virtual colonoscopy. In the virtual colonoscopy use, the second reader provides another option to a traditional colonoscopy.
CAD is being used in mammography, but some studies do not support its’ use do to greater harm in using CAD for mammogram analysis of cancer. The issue is that CAD for mammogram use has a low success rate below 15%. In addition, CAD for mammography increases the need of biopsies for the patient, according to some studies.
The primary area where CAD is beginning to be used includes cranial, pulmonary, abdominal area, and colonoscopy. In the four areas mentioned, only virtual colonoscopy is where CAD is used as a pre-screen for cancer. In the cranial, pulmonary, and abdominal analysis, CAD is used as a second reader to the primary oncologist evaluation.
Computer aided detection is an emerging technology used in medicine for either as a second reader or a first reader in pre-screening of cancer. Colonoscopy is the leading field of CAD as a first reader, pre-screener.

Why computer is aided diagnosis research performed? Computer aided diagnosis, CAD, is performed to develop a technology to reduce reading errors. A reading error is where an expert may determine as area to be positive when it is not, requiring a biopsy, or when an expert determines an area to be negative, when it is positive, delaying the needed treatment of a patient. Some of the reading errors are caused form false-positives which require a biopsy for evaluation. A biopsy is a tissue specimen of the affected area. Another aspect is a false negative in which the patient loses critical time in treatment. A mis-reading can occur even without an expert reader due to various reasons. Therefore, CAD is researched as a way to help the physician and researcher to better serve the patient.

A Status Report of Computer Aided Diagnosis for Breast, Cranial, Colon, and Abdominal Evaluation

Product Description

Le cancer colo-rectal est, en termes d’incidence, le cancer digestif le plus fréquent. Plus de 70 % d’entre eux sont localisés sur l’anse sigmoïde du côlon gauche. La colectomie segmentaire sigmoïdienne pour cancer est donc l’un des actes de chirurgie digestive le plus souvent réalisé. L’intérêt de l’abord laparoscopique dans ces circonstances a été reconnu depuis plusieurs années, en termes de réduction des complications pariétales, des douleurs post opératoires, de la rapidité de récupération d’un retour à un état physique normal, d’ordre esthétique même si cela est secondaire, et surtout de qualité de vie, par plusieurs études contrôlées convergentes.

Précis d’intervention. La sigmoïdectomie laparoscopique pour cancer

Product Description

- Takes a problem oriented approach to discuss the key concepts in the field of colorectal surgery.

- Includes recent progress in imaging techniques and how they are useful to the surgeon.

- Highlghts not only the medical apsects of coloproctology, but the legal concerns for the physician as well.

Progress in Colorectal Surgery